Search

Your search keyword '"D'ANNA, BARBARA"' showing total 109 results
Start Over Author "D'ANNA, BARBARA" Publisher lippincott williams & wilkins
109 results on '"D'ANNA, BARBARA"'

3. Contribution of Etiologic Cofactors to CIN3+ Risk Among Women With Human Papillomavirus-Positive Screening Test Results.

Author

Demarco, Maria, Egemen, Didem, Hyun, Noorie, Chen, Xiaojian, Moscicki, Anna-Barbara, Cheung, Li, Carter-Pokras, Olivia, Hammer, Anne, Gage, Julia C., Clarke, Megan A., Castle, Philip E., Befano, Brian, Chen, Jie, Dallal, Cher, He, Xin, Desai, Kanan, Lorey, Thomas, Poitras, Nancy, Raine-Bennett, Tina R., and Perkins, Rebecca B.

Published
2022
Full Text
View/download PDF

15. Screening for Anal Cancer in Women.

Author

Moscicki, Anna-Barbara, Darragh, Teresa M., Berry-Lawhorn, J. Michael, Roberts, Jennifer M., Khan, Michelle J., Boardman, Lori A., Chiao, Elizabeth, Einstein, Mark H., Goldstone, Stephen E., Jav, Naomi, Likes, Wendy M., Stier, Elizabeth A., Welton, Mark L., Wiley, Dorothy J., and Palefsky, Joel M.

Published
2015
Full Text
View/download PDF

18. Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors.

Author

Sabino, Ester C, Ribeiro, Antonio L, Salemi, Vera M C, Di Lorenzo Oliveira, Claudia, Antunes, Andre P, Menezes, Marcia M, Ianni, Barbara M, Nastari, Luciano, Fernandes, Fabio, Patavino, Giuseppina M, Sachdev, Vandana, Capuani, Ligia, de Almeida-Neto, Cesar, Carrick, Danielle M, Wright, David, Kavounis, Katherine, Goncalez, Thelma T, Carneiro-Proietti, Anna Barbara, Custer, Brian, and Busch, Michael P

Published
2013
Full Text
View/download PDF

19. Ten-Year Incidence of Chagas Cardiomyopathy Among Asymptomatic Trypanosoma cruzi-Sero positive Former Blood Donors.

Author

Sabino, Ester C., Ribeiro, Antonio L., Salemi, Vera M. C., Di Lorenzo Oliveira, Claudia, Antunes, Andre P., Menezes, Marcia M., Ianni, Barbara M., Nastari, Luciano, Fernandes, Fabio, Patavino, Giuseppina M., Sachdev, Vandana, Capuani, Ligia, de Almeida-Neto, Cesar, Carrick, Danielle M., Wright, David, Kavounis, Katherine, Goncalez, Thelma T., Carneiro-Proietti, Anna Barbara, Custer, Brian, and Busch, Michael P.

Published
2013
Full Text
View/download PDF

21. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Author

Saslow,, Debbie, Solomon, Diane, Lawson, Herschel W., Killackey, Maureen, Kukasingam, Shalini L., Cain, Joanna M., Garcia, Francisco A. R., Moriarty, Ann T., Waxman, Alan G., Wilbur, David C., Wentzensen, Nicolas, Downs, Levi S. Jr, Spitzer, Mark, Moscicki, Anna-Barbara, Franco, Eduardo L., Stoler, Mark H., Schiffman, Mark, Castle, Philip E., Myers, Evan R., and Saslow, Debbie

Published
2012

23. Measurement of Mucosal Biomarkers in a Phase 1 Trial of Intravaginal 3% StarPharma LTD 7013 Gel (VivaGel) to Assess Expanded Safety.

Author

Moscicki, Anna-Barbara, Kaul, Rupert, Ma, Yifei, Scott, Mark E., Daud, Ibrahim I., Bukusi, Elizabeth A., Shiboski, Stephen, Rebbapragada, Anuradha, Huibner, Sanja, and Cohen, Craig R.

Abstract

The aim of this study was to examine the effect of the 3% StarPharma LTD 7013 gel (VivaGel) on mucosal immune markers hypothesized to be associated with HIV-1 acquisition.Phase 1, placebo-controlled, randomized, double-blind clinical trial was performed in 54 young women in the United States and Kenya. Participants used carbopol gel with and without (placebo) StarPharma LTD 7013 twice daily over 14 days. Cervical specimens were collected for cytokines, chemokines, T cells, and dendritic cells at days 0, 7, 14, and 21. A negative binomial regression model was used to assess differences between study arms.Several mucosal immune parameters were increased in the VivaGel arm compared with placebo. For cytokines D7, IL-6 (P = 0.05); D 14, interferon gamma (P = 0.03), IL-2 (P = 0.04), IL-5 (P = 0.003), and IL-10 (P = 0.001) were increased. On D7, CD8+/CD69+ T cells tended to be increased (P < 0.08); limiting analysis to visits without blood or bacterial vaginosis, these findings were stronger as follows: at D7, CD8+/CD69+ T cells were increased in the VivaGel arm (P < 0.005), as were CD4+/CD69+ cells (P = 0.001) and CD4+/CCR5+ T cells (P = 0.01). The changes described for D7 and 14 were no longer seen at D21.Markers associated with inflammation and epithelial damage were reversibly elevated in the VivaGel arm compared with the placebo arm after 7-14 days of twice daily product use. [ABSTRACT FROM AUTHOR]

Published
2012
Full Text
View/download PDF

25. Rate of and Risks for Regression of Cervical intraepithelial Neoplasia 2 in Adolescents and Young Women.

Author

Moscicki, Anna-Barbara, Yifei Ma, Wibbelsman, Charles, Darragh, Teresa M., Powers, Adaleen, Farhat, Sepideh, and Shiboski, Stephen

Subjects
*DISEASE progression, *TEENAGE girls, *YOUNG women, *FEMALE reproductive organ tumors, *DISEASES, CERVIX uteri tumors
Abstract

This article presents a study which described the natural history of cervical intraepithelial neoplasia (CIN) 2 in a prospective study of adolescents and young women. The study also examined the behavioral and biologic factors associated with regression and progression. An overview of the study population, details of the methods and a discussion on the study results are given.

Published
2010
Full Text
View/download PDF

26. Safety and Immunogenicity of a Quadrivalent Human Papillomavirus (Types 6, 11, 1 6, and 1 8) Vaccine in HIV-lnfected Children 7 to 1 2 Years Old.

Author

Levin, Myron J., Moscicki, Anna-Barbara, Lin-Ye Song, Fenton, Terrence, William A. Meyer, III, Read, Jenn!fer S., Handelsinan, Edward L., Nowak, Barbara, Sattler, Carlos A., Saah, Alfred, Radley, David R., Esser, Mark T., and Weinberg, Adriana

Subjects
*HUMAN papillomavirus vaccines, *HIV-positive children, *AIDS vaccines, *IMMUNIZATION of children, *IMMUNOASSAY
Abstract

The article presents a study which evaluates the resistance and safety of quadrivalent human papillomavirus vaccine (QHPV) among children with HIV infections who are aging seven to 12 years old. It states that the HIV-infected children have received doses of QHPV at different week intervals and Luminex immunoassay has been used in measuring the serum antibody and QHPV antigens. The results reveal that the application of QHPV among children with HIV infection is safe and immunogenic.

Published
2010
Full Text
View/download PDF

29. Oral Human Papillomavirus in Youth From the Pediatric HIV/AIDS Cohort Study.

Author

Moscicki, Anna-Barbara, Farhat, Sepideh, Tzy-Jyun Yao, Ryder, Mark I., Russell, Jonathan S., Van Dyke, Russell B., Hazra, Rohan, Shiboski, Caroline H., Yao, Tzy-Jyun, and Pediatric HIVAIDS Cohort Study

Subjects
*AIDS complications, *ORAL disease diagnosis, *PAPILLOMAVIRUS disease diagnosis, *HIV infection complications, *AIDS epidemiology, *AIDS, *HIV infections, *LONGITUDINAL method, *ORAL diseases, *PAPILLOMAVIRUS diseases, *PAPILLOMAVIRUSES, *RESEARCH funding, *VIRAL load, *CROSS-sectional method, *CD4 lymphocyte count, *GENOTYPES, *MIXED infections, *DISEASE complications
Abstract

In contrast to high rates of oral human papillomavirus (HPV) found in human immunodeficiency virus (HIV)-infected adults, only 2% of 209 perinatally HIV-infected youth had oral HPV. This rate was similar in HIV-exposed but uninfected youth. No association was found with sexual activity; however, low CD4 counts were associated with oral HPV. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

31. Risks for Cervical lntraepithelial Neoplasia 3 Among Adolescents and Young Women With Abnormal Cytology.

Author

Moscicki, Anna-Barbara, Yifei Ma, Wibbelsman, Charles, Powers, Adaleen, Darragh, Teresa M., Farhat, Sepideh, Shaber, Ruth, and Shiboski, Stephen

Subjects
*CERVIX uteri diseases, *CYTOLOGY, *PAPILLOMAVIRUSES, *MEDICAL triage, *DISEASES in women
Abstract

The article assesses the risks of cervical intraepithelial neoplasia (CIN) 3 among girls and women aged 13 to 24 years who were referred for abnormal cytology while receiving care in a large health maintenance organization. It shows that human papillomavirus 16 or 18 is associated with CIN3 and that testing may be warranted for triage of abnormal cytology.

Published
2008
Full Text
View/download PDF

34. Clinical Question: Ask the Expert.

Author

Diem, Klaus, Spitzer, Mark, Twiggs, Leo B., Cox, J. Thomas, Kaufman, Raymond H., Moscicki, Anna-Barbara, and Rubin, Mary

Abstract

The article presents answers to a question about the Pap smear finding in a 23-year old woman which is interpreted as a high grade squamous intraepithelial lesion.

Published
2008
Full Text
View/download PDF

35. Effect of Replens Gel Used with a Diaphragm on Tests for Human Papillomavirus and Other Lower Genital Tract Infections.

Author

Smith-McCune, Karen K., Tuveson, Jennifer L., Rubin, Mary M., Da Costa, Maria M., Darragh, Teresa M., Shiboski, Stephen C., Van Der Pol, Barbara, Moscicki, Anna-Barbara, Palefsky, Joel M., and Sawaya, George E.

Abstract

The article presents a study which examined the effects of vaginal lubricant Replens gel on detection of human papillomavirus (HPV) and other sexually transmissible infections. According to the study's findings, proportions with detectable HPV in the clinician-collected cervical pregel and postgel samples were not statistically different for samples with added SiHa cells. The study concluded that Replens gel used with a diaphragm does not inhibit cervical HPV testing or cervical cytology quality.

Published
2006
Full Text
View/download PDF

40. American cancer society guideline for the early detection of cervical neoplasia and cancer.

Author

Saslow D, Runowicz CD, Solomon D, Moscicki A, Smith RA, Eyre HJ, Cohen C, Saslow, Debbie, Runowicz, Carolyn D, Solomon, Diane, Moscicki, Anna-Barbara, Smith, Robert A, Eyre, Harmon J, and Cohen, Carmel

Abstract

An update to the American Cancer Society (ACS) guideline regarding screening for the early detection of cervical neoplasia and cancer, based on recommendations from a formal review and recent workshop, is presented. The new screening recommendations address when to begin screening, when screening may be discontinued, whether to screen women who have had a hysterectomy, appropriate screening intervals, and new screening technologies, including liquid-based cytology and HPV DNA testing. [ABSTRACT FROM AUTHOR]

Published
2003
Full Text
View/download PDF

47. Clinical Question: Ask the Experts.

Author

Rubin, Mary M., Moscicki, Anna-Barbara, and Twiggs, Leo B.

Abstract

Presents a response from various medical professionals about the human papillomavirus infection of the cervix of a 14-year-old girl. Mary M. Rubin; Anna-Barbara Moscicki; Leo B. Twiggs.

Published
2003

49. Factors Associated with Leg Ulcers in Adults with Sickle Cell Disease in Brazil.

Author

Reis de Souza V, Kelly S, Cerdeira Sabino E, Mendes de Oliveira F, Silva T, Miranda Teixeira C, Máximo C, Loureiro P, Barbara de Freitas Carneiro-Proietti A, Gomes I, Custer B, and de Almeida-Neto C

Subjects
Humans, Adult, Male, Brazil epidemiology, Cross-Sectional Studies, Hemoglobins, Bilirubin, Anemia, Sickle Cell complications, Anemia, Sickle Cell epidemiology, Leg Ulcer etiology, Leg Ulcer complications
Abstract

Objective: To define the prevalence of leg ulcers and identify the clinical and laboratory factors associated with leg ulcers in adult participants., Methods: The authors conducted a cross-sectional study of 1,109 patients who were 18 years or older with SS or Sβ0-thalassemia genotypes from a Brazilian cohort. Investigators assessed the prevalence of factors associated with leg ulcers from 2013 to 2017., Results: The prevalence of leg ulcers was 21%. Increasing age (odds ratio [OR], 1.07; range, 1.06-1.09), male sex (OR, 2.03; range, 1.44-2.87), treatment with chronic transfusion therapy (OR, 1.88; range, 1.15-3.03), higher indirect bilirubin levels (OR, 1.48; range, 1.02-2.16), and low hemoglobin levels (OR, 2.17; range, 1.52-3.11) were associated with leg ulcers. Participants who self-reported as Black (OR, 6.75; range, 2.63-21.32), mixed (OR, 3.91; range, 1.55-12.20), and other/unknown (OR, 3.84; range, 1.04-15.24) were more likely to have leg ulcers compared with those who self-reported as White., Conclusions: The prevalence of leg ulcers in this Brazilian cohort was higher than the prevalence reported in developed countries. Known factors such as age and male sex were corroborated. The increased bilirubin level and decreased hemoglobin levels among participants with leg ulcers support the hypothesis that hemolysis is correlated with leg ulcer pathogenesis. Self-reported black skin color was an independent predictor of leg ulcers and warrants further study to understand the etiology and implications of this finding., (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)

Published
2023
Full Text
View/download PDF

50. Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.

Author

Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya GF, Wentzensen N, and Schiffman M

Abstract

Competing Interests: Conflict of interest: The following listed authors have no conflicts of interest to disclose: Drs. Perkins, Chelmow, Garcia, Kim, Nayar, Saraiya, and Sawaya. The following listed authors have conflicts of interest:

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results